We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$20.8B
Cap. Flow
% of AUM
98.76%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.1B |
| 2 |
Apple
AAPL
|
+$895M |
| 3 |
Microsoft
MSFT
|
+$781M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$593M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$523M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 9.59% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Charles River Laboratories
CRL
$11.3B
| $525K | ﹤0.01% |
+2,633
| New | +$478K |
|
927
Fabrinet
FN
$14.9B
| $523K | ﹤0.01% |
+1,149
| New | +$500K |
|
928
Blackbaud
BLKB
$1.94B
| $523K | ﹤0.01% |
+8,255
| New | +$511K |
|
929
Moderna
MRNA
$21.6B
| $520K | ﹤0.01% |
+17,634
| New | +$479K |
|
930
Schwab US Dividend Equity ETF
SCHD
$104B
| $520K | ﹤0.01% |
+18,951
| New | +$515K |
|
931
Honda
HMC
$39.8B
| $518K | ﹤0.01% |
+17,576
| New | +$534K |
|
932
Forestar Group
FOR
$1.48B
| $517K | ﹤0.01% |
+20,973
| New | +$535K |
|
933
Coinbase
COIN
$42.2B
| $515K | ﹤0.01% |
+2,278
| New | +$679K |
|
934
Suncor Energy
SU
$77.7B
| $515K | ﹤0.01% |
+11,604
| New | +$490K |
|
935
iShares MSCI India ETF
INDA
$6.81B
| $513K | ﹤0.01% |
+9,497
| New | +$512K |
|
936
Vanguard S&P 500 Growth ETF
VOOG
$24.7B
| $513K | ﹤0.01% |
+6,918
| New | +$509K |
|
937
Rio Tinto
RIO
$152B
| $510K | ﹤0.01% |
+6,378
| New | +$459K |
|
938
Kymera Therapeutics
KYMR
$8.66B
| $509K | ﹤0.01% |
+6,544
| New | +$442K |
|
|
ECG
939
Everus Construction Group
ECG
$5.57B
| $509K | ﹤0.01% |
+5,945
| New | +$532K |
|
940
W.R. Berkley
WRB
$28.1B
| $508K | ﹤0.01% |
+7,241
| New | +$534K |
|
941
British American Tobacco
BTI
$136B
| $504K | ﹤0.01% |
+8,903
| New | +$486K |
|
942
Fresenius Medical Care
FMS
$13.4B
| $502K | ﹤0.01% |
+21,083
| New | +$524K |
|
943
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
| $502K | ﹤0.01% |
+3,501
| New | +$499K |
|
|
SEE
944
DELISTED
Sealed Air
SEE
| $501K | ﹤0.01% |
+12,101
| New | +$468K |
|
945
Westlake Chemical Partners
WLKP
$772M
| $499K | ﹤0.01% |
+26,278
| New | +$508K |
|
946
Natera
NTRA
$36.4B
| $499K | ﹤0.01% |
+2,178
| New | +$454K |
|
947
Reinsurance Group of America
RGA
$15.5B
| $498K | ﹤0.01% |
+2,448
| New | +$473K |
|
948
Occidental Petroleum
OXY
$55.7B
| $498K | ﹤0.01% |
+12,105
| New | +$505K |
|
949
Huntington Ingalls Industries
HII
$11B
| $497K | ﹤0.01% |
+1,460
| New | +$453K |
|
950
Guardant Health
GH
$19.1B
| $496K | ﹤0.01% |
+4,853
| New | +$434K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 1,431 positions worth $21.1B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
- Glenmede Trust's ten largest holdings make up 27% of its $21.1B portfolio in Q4 2025.
- Glenmede Trust disclosed 1,431 positions in Q4 2025, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q4 2025, filed 17 Feb 2026.